ESMO 2017: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma
Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage…
Browsing: CheckMate 238 trial
Australian researchers stopping melanoma in its tracks
A team of Australian researchers has made the ultimate move in the battle to beat…